• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 277/10 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 277/10

Total number of patents in this class: 50

10-year publication summary

1
2
1
3
0
0
2
2
4
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
University of Florida Research Foundation, Inc.
4077
8
BASF SE
21083
4
The Board of Trustees of the University of Illinois
2714
3
Kyoto University
2840
3
Glaxo Group Limited
4126
2
Jawaharlal Nehru Centre for Advanced Scientific Research
86
2
Flagship Pioneering Innovations VI, LLC.
507
2
Myrodia Therapeutics Co., Ltd.
2
2
L'OREAL, Société Anonyme
15809
1
Syngenta Participations AG
1745
1
FUJIFILM Corporation
29775
1
Michelin Recherche et Technique S.A.
2141
1
Amira Pharmaceuticals, Inc.
67
1
Epitech Group S.r.l.
22
1
Institut National de La Sante et de La Recherche Medicale (inserm)
2958
1
Institut Pasteur de Lille
178
1
Scent Science International Inc.
16
1
Shionogi & Co., Ltd.
838
1
The United States of America as represented by the Department of Health and Human Services
79
1
The United States of America as represented by the National Institutes of Health (NIH)
3
1
Other owners 12